Strategic Partnerships AP-HP actively engages in international collaborations with universities and research institutes (e.g., Cairo University, The Theodor Bilharz Research Institute, Université Paris Cité, Beaujon Hospital, Owkin, Pixyl.ai, AFM-Telethon collaborators). This presents a clear avenue for joint tech and clinical trial opportunities, AI in diagnostics, and gene therapy collaborations that can be pursued to expand co-development and funded programs.

Digital Health The institution has a history of digital health initiatives and AI partnerships (Owkin, Bernoulli Lab, The Bernoulli Lab Joint Challenge, AI for oncology, Pixyl AI collaboration). This indicates an openness to AI, data analytics, and ML-enabled solutions, offering a fertile market for advanced analytics, imaging AI, and data management platforms tailored for large hospital networks.

Large Scale Network With over 10,001 employees across 39 hospitals and serving 8 million patients annually, AP-HP represents a substantial multi-site deployment opportunity for standardized hospital IT systems, EHR enhancements, cybersecurity, cloud hosting, and interoperability solutions designed for complex public health networks.

Clinical Research Frequent academic and clinical collaborations (university partners, gene therapy vector production, kidney disease research) indicate ongoing demand for research support services, data infrastructure, regulatory consulting, and scalable biorepository or clinical trial platforms that can integrate with hospital workflows.

Public Health Scale As a public health service operating 24/7, AP-HP seeks reliable, compliant, and cost-effective solutions for emergency and routine care delivery, including patient engagement, remote monitoring, and supply chain resilience—areas where mission-critical uptime and compliance are key selling points.